Target Price | $272.94 |
Price | $289.00 |
Deviation |
5.56%
register free of charge
|
Number of Estimates | 17 |
17 Analysts have issued a price target CME Group a 2026 .
The average CME Group a target price is $272.94.
This is
5.56%
register free of charge
$305.00
5.54%
register free of charge
$211.00
26.99%
register free of charge
|
|
A rating was issued by 20 analysts: 8 Analysts recommend CME Group a to buy, 8 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the CME Group a stock has an average upside potential 2026 of
5.56%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 10.21 | 6.61 |
5.94% | 35.22% | |
EBITDA Margin | 81.76% | 71.77% |
2.08% | 12.22% | |
Net Margin | 34.10% | 58.78% |
16.19% | 72.37% |
15 Analysts have issued a sales forecast CME Group a 2025 . The average CME Group a sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an CME Group a EBITDA forecast 2025. The average CME Group a EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
8 CME Group a Analysts have issued a net profit forecast 2025. The average CME Group a net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 9.67 | 10.81 |
9.14% | 11.79% | |
P/E | 26.74 | |
EV/Sales | 16.04 |
8 Analysts have issued a CME Group a forecast for earnings per share. The average CME Group a EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
UBS |
Locked
➜
Locked
|
Locked | Apr 25 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | Apr 24 2025 |
Keefe, Bruyette & Woods |
Locked
➜
Locked
|
Locked | Apr 24 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | Apr 24 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
Oppenheimer |
Locked
➜
Locked
|
Locked | Apr 11 2025 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
Analyst Rating | Date |
---|---|
Locked
UBS:
Locked
➜
Locked
|
Apr 25 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
Apr 24 2025 |
Locked
Keefe, Bruyette & Woods:
Locked
➜
Locked
|
Apr 24 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
Apr 24 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Apr 23 2025 |
Locked
Oppenheimer:
Locked
➜
Locked
|
Apr 11 2025 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Apr 08 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.